How Much Does It Cost to Get Your Medical Device CE Marked?
CE marking is a crucial regulatory requirement for medical devices in the European Union. It signifies compliance with the Medical Device Regulation (MDR) and grants market access across EU member states. However, achieving this certification can be costly, requiring extensive documentation, testing, and approvals.
From my experience as a clinical evaluation expert, many manufacturers underestimate the financial and time investments needed to obtain CE marking. A recent report by the French medical technology association SNITEM highlights these challenges, providing valuable insights into the cost burden of MDR compliance.
The Cost of Obtaining a CE Mark for Medical Devices
According to SNITEM’s data, the total cost of certifying a single medical device under MDR ranges between €200,000 and €600,000. This includes compliance with all regulatory requirements, covering clinical evaluation, risk assessment, and notified body approval. The cost varies based on factors such as device classification, clinical study requirements, and regulatory consultancy fees.
A European Union survey of 501 medical device companies further emphasizes the financial challenges:
- 242 manufacturers aim to comply with MDR for their entire product portfolio.
- 159 companies believe full compliance across all product lines is financially unsustainable.
- 70 companies face significant delays in certification.
- 60 companies report a lack of clinical evidence to meet MDR requirements.
The stringent regulations have forced many businesses to downsize their product offerings or completely halt new product development. This is especially true for small and medium-sized enterprises (SMEs), which struggle the most with the rising costs and complexities of MDR compliance.
Breakdown of CE Marking Costs for Medical Devices
The total cost of CE marking includes several key components. Below is a breakdown of the main cost drivers:
| Cost Component | Estimated Cost (€) |
|---|---|
| Regulatory Consulting Fees | 30,000 – 100,000 |
| Notified Body Certification | 50,000 – 250,000 |
| Clinical Investigations | 100,000 – 500,000 |
| Product Testing & Validation | 20,000 – 80,000 |
| Technical Documentation | 10,000 – 50,000 |
| Post-Market Surveillance | 10,000 – 30,000 |
| Software Compliance (if applicable) | 20,000 – 100,000 |
Each of these components is crucial to obtaining CE certification, with the highest costs usually coming from clinical investigations and notified body assessments.
What your device class actually changes
Device class is the largest cost driver, and the Regulation is explicit about why. Of the seven components above, five apply to every manufacturer. Only two are gated by class, and those two are the expensive ones.
| Class | Notified body | Technical documentation assessed | Clinical investigation |
|---|---|---|---|
| Class I | Not required (Art 52(7)) | Not assessed by a notified body | Not required |
| Class I sterile, measuring or reusable surgical | Required, limited scope | Sterility, metrology or reuse only | Not required |
| Class IIa | Required (Art 52(6)) | Representative basis, at least one device per category | Not required |
| Class IIb, non-implantable | Required (Art 52(4)) | Representative basis, at least one per generic device group | Not required |
| Class IIb, implantable | Required | Every device (Annex IX Section 4) | Mandatory unless exempt (Art 61(4)) |
| Class III | Required (Art 52(3)) | Every device (Annex IX Section 4) | Mandatory unless exempt (Art 61(4)) |
The exemptions matter as much as the rule. Article 61(4) lets you avoid a clinical investigation on an implantable or Class III device where it modifies one you already market, equivalence is demonstrated under Annex XIV and endorsed by your notified body, and the marketed device’s clinical evaluation is sufficient. Article 61(5) extends that to another manufacturer’s device, but only with a contract giving you full and ongoing access to their technical documentation. That clause is where most equivalence routes fail. Article 61(6) covers legacy devices with sufficient clinical data, and Article 61(10) allows a non-clinical justification where clinical data is not appropriate.
A note on per-class price tags. You will find pages quoting one figure per class. Treat them carefully. The components above do not all reach their maximum on the same device, so adding them up produces a number nobody has ever paid. What the Regulation fixes is which components you must budget for. How much your device needs of each depends on your evidence, your predicate and your notified body’s queries, and anyone quoting a single number has skipped that question.
Factors Affecting CE Marking Costs
Several factors influence how much a company spends on CE marking:
1. Medical Device Classification
MDR classifies devices into Class I, IIa, IIb, and III based on risk level. Higher-risk devices require more extensive testing and clinical data, increasing costs significantly.
2. Clinical Evidence Requirements
MDR places a strong emphasis on clinical data. Devices without sufficient clinical evidence must conduct new clinical trials, which can be highly expensive.
3. Notified Body Fees
Notified bodies charge different rates depending on the complexity of the evaluation. Devices requiring rigorous reviews (e.g., implantable or life-sustaining devices) have higher certification fees.
4. Need for Expert Consultancy
Many manufacturers hire regulatory consultants to navigate MDR compliance. While this adds upfront costs, it can prevent costly delays and certification failures.
5. Post-Market Surveillance (PMS)
Under MDR, manufacturers must implement post-market surveillance and vigilance reporting systems, which add ongoing costs even after obtaining CE marking.
How to Reduce the Cost of CE Marking
Despite the high costs, companies can take proactive steps to manage their expenses:
1. Early Clinical Planning
The earlier clinical evaluation is incorporated into device development, the easier it is to meet MDR requirements without excessive spending on additional trials.
2. Portfolio Prioritization
Instead of attempting to certify all products at once, companies should prioritize high-potential devices that have strong clinical data and market demand.
3. Selecting the Right Notified Body
Notified bodies vary in pricing, expertise, and availability. Choosing the most suitable notified body can help reduce certification timelines and costs.
4. Leveraging Existing Data
If a device has been on the market before MDR, manufacturers should leverage historical clinical data to minimize additional testing requirements.
5. Partnering with Experts
Working with regulatory experts helps streamline the process, reducing unnecessary costs associated with delays, documentation errors, or failed applications.
CE Marking Costs for Startups vs. Established Companies
Startups and smaller manufacturers face unique challenges when dealing with CE certification costs. Unlike large corporations with dedicated compliance teams, SMEs often struggle with:
- Limited budgets for regulatory compliance
- Lack of in-house expertise
- Challenges in funding clinical trials
- Delays in securing notified body approval
To mitigate these issues, startups should seek grants, venture funding, or partner with experienced regulatory consultants.
On the other hand, established companies can allocate resources more effectively, benefiting from internal regulatory teams and previous experience in navigating EU compliance.
The Future of CE Marking Costs Under MDR
With MDR fully implemented, regulatory scrutiny has increased. This trend is expected to continue driving up certification costs as more stringent post-market surveillance and reporting requirements are enforced.
However, the EU Commission has recognized these challenges and may introduce regulatory adjustments to ease the burden on manufacturers. Some potential changes include:
- Extended transition periods for certain devices.
- Regulatory support for SMEs struggling with certification costs.
- Streamlined approval pathways for low-risk innovations.
Manufacturers must stay updated on these regulatory changes to optimize their CE marking strategies.
FAQs
1) How much does it cost to get a medical device CE marked?
The cost of CE marking under MDR can range from €200,000 to €600,000, depending on factors such as clinical trials, notified body fees, and regulatory consulting.
2) Why is CE marking so expensive?
CE marking requires extensive compliance with MDR requirements, including clinical evaluations, risk assessments, and regulatory documentation, all of which contribute to high costs.
3) Are there ways to reduce CE certification costs?
Yes. Companies can plan early, prioritize high-potential devices, choose the right notified body, leverage existing clinical data, and work with regulatory consultants to manage costs efficiently.
4) Do startups face higher challenges in CE certification?
Startups often struggle with limited budgets and expertise, making it harder to meet MDR requirements. However, they can seek grants, partnerships, and expert guidance to ease the process.
5) How long does it take to get CE certification?
The CE marking process under MDR can take anywhere from 12 to 36 months, depending on device classification, clinical study requirements, and notified body availability.
6) Will CE marking costs increase in the future?
Yes. With MDR enforcement becoming stricter, costs may rise due to additional post-market surveillance, clinical evidence requirements, and regulatory scrutiny.
Final Thoughts
Obtaining a CE mark under MDR is a significant investment, but it is necessary for accessing the European market. While costs can be high, strategic planning, expert guidance, and efficient resource allocation can help companies navigate the certification process effectively.
If you’re currently preparing for MDR compliance and CE marking, don’t hesitate to reach out for expert advice. With the right approach, these regulations don’t have to become insurmountable obstacles.
PS: For more information, subscribe to my newsletter and get access to exclusive content, private insights, and expert guidance on MDR compliance and CE marking: Subscribe Here
✌️ Peace,
Hatem Rabeh, MD, MSc Ing
Your Clinical Evaluation Expert & Partner
Follow me for more insights and practical advice!
